Alpha Tau Medical (DRTS) Earnings Date & Reports

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

DRTS is expected to report earnings to fall 3.63% to -13 cents per share on May 21

Alpha Tau Medical DRTS Stock Earnings Reports

Q1'25

Est.

$-0.13

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.02

Q2'24

Est.

$-0.11

Q1'24

Beat

by $0.02

The last earnings report on March 12 showed earnings per share of -13 cents, missing the estimate of -11 cents. With 45.96K shares outstanding, the current market capitalization sits at 174.54M.

View a ticker or compare two or three

Compare

DRTS